|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 113, Issue 3 383-390, Copyright © 2000 by Company of Biologists
JOURNAL ARTICLES |
P Batard, MN Monier, N Fortunel, K Ducos, P Sansilvestri-Morel, T Phan, A Hatzfeld and JA Hatzfeld
Laboratoire de Biologie Cellulaire et Moleculaire des Facteurs de Croissance, UPR 1983 du Centre National de la Recherche Scientifique, IFC1, rue Guy Moquet, France.
Somatic stem cells are largely quiescent in spite of their considerable proliferative potential. Transforming growth factor-(beta)1 (TGF-(beta)1) appears to be a good candidate for controlling this quiescence. Indeed, various mutations in the TGF-beta signalling pathway are responsible for neoplasic proliferation of primitive stem/progenitor cells in human tissues of various origins. In hemopoietic single cell culture assays, blocking autocrine and endogeneous TGF-(beta)1 triggers the cell cycling of high proliferative potential undifferenciated stem/progenitor cells. However, it has never been demonstrated whether TGF-(beta)1 has an apoptotic effect or a differentiating effect on these primitive cells, as already described for more mature cells. Using single cell experiments both in liquid or semi-solid culture assays and dye tracking experiments by flow cytometry, we demonstrate that low, physiological concentrations of TGF-(beta)1, which specifically maintain primitive human hemopoietic stem/progenitor cells in quiescence, have a reversible effect and do not induce apoptosis. We moreover demonstrate that these low concentrations prevent the rapid loss of the mucin-like protein CD34, a most common marker of immature hematopoietic stem/progenitor cells, which is progressively lost during differentiation. TGF-(beta)1 not only up-modulated the CD34 antigen before S phase entry but also maintained a high level of CD34 expression on cells which had escaped cell cycle inhibition, suggesting that proliferation inhibition and differentiation control by TGF-(beta)1 may be independent. These data provide additional evidence that TGF-(beta)1 acts as a key physiological factor ensuring the maintenance of a stem cell reserve.
This article has been cited by other articles:
|
|
 |
|
  R. Brunsing, S. A. Omori, F. Weber, A. Bicknell, L. Friend, R. Rickert, and M. Niwa B- and T-cell Development Both Involve Activity of the Unfolded Protein Response Pathway J. Biol. Chem., June 27, 2008; 283(26): 17954 - 17961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Blank, G. Karlsson, and S. Karlsson Signaling pathways governing stem-cell fate Blood, January 15, 2008; 111(2): 492 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Goldberg, O. Alpdogan, S. J. Muriglan, M. V. Hammett, M. K. Milton, J. M. Eng, V. M. Hubbard, A. Kochman, L. M. Willis, A. S. Greenberg, et al. Enhanced Immune Reconstitution by Sex Steroid Ablation following Allogeneic Hemopoietic Stem Cell Transplantation J. Immunol., June 1, 2007; 178(11): 7473 - 7484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Blank, G. Karlsson, J. L. Moody, T. Utsugisawa, M. Magnusson, S. Singbrant, J. Larsson, and S. Karlsson Smad7 promotes self-renewal of hematopoietic stem cells Blood, December 15, 2006; 108(13): 4246 - 4254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Campard, M. Vasse, S. Rose-John, F. Poyer, M. Lamacz, and J.-P. Vannier Multilevel Regulation of IL-6R by IL-6-sIL-6R Fusion Protein According to the Primitiveness of Peripheral Blood-Derived CD133+ Cells Stem Cells, May 1, 2006; 24(5): 1302 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Hmama, K. Sendide, A. Talal, R. Garcia, K. Dobos, and N. E. Reiner Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1{alpha},25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway J. Cell Sci., April 15, 2004; 117(10): 2131 - 2140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Bohmer IL-3-Dependent Early Erythropoiesis Is Stimulated by Autocrine Transforming Growth Factor Beta Stem Cells, March 1, 2004; 22(2): 216 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Larsson, U. Blank, H. Helgadottir, J. M. Bjornsson, M. Ehinger, M.-J. Goumans, X. Fan, P. Leveen, and S. Karlsson TGF-{beta} signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro Blood, November 1, 2003; 102(9): 3129 - 3135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. O. Fortunel, J. A. Hatzfeld, P.-A. Rosemary, C. Ferraris, M.-N. Monier, V. Haydont, J. Longuet, B. Brethon, B. Lim, I. Castiel, et al. Long-term expansion of human functional epidermal precursor cells: promotion of extensive amplification by low TGF-{beta}1 concentrations J. Cell Sci., October 1, 2003; 116(19): 4043 - 4052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Akel, C. Petrow-Sadowski, M. J. Laughlin, and F. W. Ruscetti Neutralization of Autocrine Transforming Growth Factor-{beta} in Human Cord Blood CD34+CD38-Lin- Cells Promotes Stem-Cell-Factor-Mediated Erythropoietin-Independent Early Erythroid Progenitor Development and Reduces Terminal Differentiation Stem Cells, September 1, 2003; 21(5): 557 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Chen, G. Zhou, T. Juan, S. M. Colicos, J. P. Cannon, M. Cabriera-Hansen, C. F. Meyer, R. Jurecic, N. G. Copeland, D. J. Gilbert, et al. The Dual Specificity JKAP Specifically Activates the c-Jun N-terminal Kinase Pathway J. Biol. Chem., September 20, 2002; 277(39): 36592 - 36601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Dao, J. Hwa, and J. A. Nolta Molecular mechanism of transforming growth factor beta -mediated cell-cycle modulation in primary human CD34+ progenitors Blood, January 15, 2002; 99(2): 499 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis Blood, September 15, 2000; 96(6): 2022 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Spagnoli, C Cicchini, M Tripodi, and M. Weiss Inhibition of MMH (Met murine hepatocyte) cell differentiation by TGF(beta) is abrogated by pre-treatment with the heritable differentiation effector FGF1 J. Cell Sci., January 10, 2000; 113(20): 3639 - 3647. [Abstract] [PDF]
|
|
